300683 Wuhan Hiteck Biological Pharma
- 30.35
- -1.55-4.86%
Wuhan Hiteck Biological Pharma News
Haite Biotech: Report for the third quarter of 2024
Haite Biotech: 2024 Semi-Annual Report Summary
Haite Biotech: 2024 Semi-Annual Report
Haite Biotech: 2023 Annual Report Summary
Haite Biotech: 2023 Annual Report
Haite Biotech: Report for the first quarter of 2024
Haite Biotech: 2023 performance forecast
Haite Biotech: Report for the third quarter of 2023
Haite Biotech: Semi-Annual Report 2023
Haite Biotech: Summary of the 2023 Semi-Annual Report
Hyte Biotech: 2022 Annual Report
Hyte Biotech: Report for the first quarter of 2023
Hyte Biotech: 2022 Annual Report Summary
Haite Biotech: 2022 Annual Results Forecast
Hyte Biotech: Report for the third quarter of 2022
Haite Biotech: 2022 Semi-Annual Report of Wuhan Haite Biopharmaceutical Co., Ltd. (after correction)
Hyte Biotech: 2022 Semi-Annual Report
Hyte Biotech: 2022 Semi-Annual Report Summary
Hyte Biotech: Report for the first quarter of 2022
Hyte Biotech: 2021 Annual Report
Analysis
Price Target
No Data
No Data